Contrast-enhanced ultrasound with Perflubutane in massive postpartum hemorrhage

Contrast-enhanced ultrasound with Perflubutane in massive postpartum hemorrhage - Contrast-enhanced ultrasound with Perflubutane in massive postpartum hemorrhage

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010541

Enrollment

Registered

2013-06-01

Start date

2013-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postpartum hemorrhage

Interventions

intravenous administration of Perflubutane

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: patients with massive postpartum hemorrhage

Exclusion criteria

Exclusion criteria: patients with allergy to egg

Design outcomes

Primary

Measure	Time frame
Whether blood point in the uterus could be detected or not	—

Countries

Japan

Contacts

Public ContactKaoru Kawasaki

Kyoto University, Graduate School of Medicine Obstetrics and Gynecogy

kkaoru@kuhp.kyoto-u.ac.jp075-751-3269

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026